Niagen Bioscience (NAGE) EBT (2010 - 2026)
Niagen Bioscience (NAGE) reported EBT of $6.7 million for Q1 2026, up 28.75% year-over-year from $5.2 million in Q1 2025, and up 52.24% quarter-over-quarter from $4.4 million in Q4 2025.
Niagen Bioscience (NAGE) EBT (2010 - 2026) Analysis & Trends
Niagen Bioscience (NAGE) has 17 years of EBT data on file, last reported at $6.7 million in Q1 2026.
- EBT for Q1 2026 came in at $6.7 million, up 28.75% year-over-year; the trailing twelve-month figure through Mar 2026 was $19.7 million (up 35.11% YoY), and the FY2025 annual result was $18.2 million, up 105.44% from the prior year.
- EBT improved to $6.7 million in Q1 2026 per NAGE's latest filing, from $4.4 million in the prior quarter.
- Over five years, EBT peaked at $7.5 million in Q4 2024 and troughed at -$7.7 million in Q1 2022.
- A 5-year average of $595705.9 and a median of -$15000.0 in 2024 frame the typical range for EBT.
- On a YoY basis, EBT climbed as much as 25013.33% in 2025 and fell as far as 40.89% in 2025.
- A 5-year view of EBT shows it stood at -$1.4 million in 2022, then surged by 107.89% to $114000.0 in 2023, then jumped by 6464.91% to $7.5 million in 2024, then sank by 40.89% to $4.4 million in 2025, then soared by 52.24% to $6.7 million in 2026.
- Business Quant data shows NAGE's EBT at $6.7 million in Q1 2026, $4.4 million in Q4 2025, and $4.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 19.60 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -15.31 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | -3.18 Mn |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | -1.50 Mn |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 1.25 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -56.48 Mn |
| 10 | Niagen Bioscience | 269.32 Mn | 202.77 Mn | 19.98 Mn | 6.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.74 Mn |
| Dec 31, 2025 | 4.42 Mn |
| Sep 30, 2025 | 4.80 Mn |
| Jun 30, 2025 | 3.74 Mn |
| Mar 31, 2025 | 5.23 Mn |
| Dec 31, 2024 | 7.48 Mn |
| Sep 30, 2024 | 1.88 Mn |
| Jun 30, 2024 | -15,000.00 |
| Mar 31, 2024 | -492,000.00 |
| Dec 31, 2023 | 114,000.00 |
| Sep 30, 2023 | -959,000.00 |
| Jun 30, 2023 | -2.19 Mn |
| Mar 31, 2023 | -1.97 Mn |
| Dec 31, 2022 | -1.44 Mn |
| Sep 30, 2022 | -3.07 Mn |
| Jun 30, 2022 | -6.40 Mn |
| Mar 31, 2022 | -7.74 Mn |
| Dec 31, 2021 | -5.33 Mn |
| Sep 30, 2021 | -8.86 Mn |
| Jun 30, 2021 | -5.57 Mn |